Skip to main content
. Author manuscript; available in PMC: 2023 Dec 9.
Published in final edited form as: Adv Pharmacol. 2021 Dec 13;93:275–333. doi: 10.1016/bs.apha.2021.10.006

Table 1.

Receptor binding profiles of several major cannabinoids on CB1, CB2 and other putative cannabinoid receptors.

Drug CB1 (Ki, nM) CB2 (Ki, nM) GPR55 (EC50, nM) TRPV1 (EC50, μM) PPARγ (EC50, μM)
Anandamide (AEA) 61–543 279–1940 18 0.16–1.15 8–10
2-Arachidonoylglycerol (2-AG) 58–472 145, 1400 3 8.4–26 10–30
Δ9-Tetrahydrocannabinol (THC) 5.05–80.3 3.13–75.3 8 >100 0.3
WIN55,212-2 (WIN) 1.89–123 0.28–16.2 N.D. >100 10
CP55940 0.5–5.0 0.69–2.8 5 >100 10
HU-210 0.06–0.73 0.17–0.52 26 1.2 N.D.